Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
Price:
3.84 CNY
-1.03%
Market Closed
Updated:
May 21, 2024
Guizhou Xinbang Pharmaceutical Co Ltd
Gross Profit
|
Guizhou Xinbang Pharmaceutical Co Ltd
Gross Profit Peer Comparison
Comparables:
C
1093
H
3692
600436
600276
000538
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Guizhou Xinbang Pharmaceutical Co Ltd
SZSE:002390
|
Gross Profit
¥1.2B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
13%
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Gross Profit
¥22.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
14%
|
CAGR 10-Years
24%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Gross Profit
¥9.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Gross Profit
¥4.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
18%
|
CAGR 10-Years
20%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Gross Profit
¥19.5B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
14%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Gross Profit
¥10.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
See Also
What is Guizhou Xinbang Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
1.2B
CNY
1.2B
CNY
Based on the financial report for Mar 31, 2024, Guizhou Xinbang Pharmaceutical Co Ltd's Gross Profit amounts to 1.2B CNY.
What is Guizhou Xinbang Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 10Y
13%
13%
Over the last year, the Gross Profit growth was 1%. The average annual Gross Profit growth rates for Guizhou Xinbang Pharmaceutical Co Ltd have been -4% over the past three years , -3% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
